|
PEN
|
Penumbra, Inc.
|
0.72%
|
US
|
NYSE
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
6160
|
Beigene Ltd
|
0.67%
|
HK
|
HK
|
|
BIIB
|
Biogen Idec Inc.
|
0.58%
|
US
|
NASDAQ
|
|
SCHW
|
Charles Schwab Corporation (The)
|
0.56%
|
US
|
NYSE
|
|
HZNP
|
Horizon Pharma, Inc.
|
0.56%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
0.54%
|
US
|
NASDAQ
|
|
AMG
|
Affiliated Managers Group, Inc.
|
0.54%
|
US
|
NYSE
|
|
BBSE3
|
BB Seguridade Participacoes SA
|
0.53%
|
BR
|
SA
|
|
ENSG
|
The Ensign Group, Inc.
|
0.53%
|
US
|
NASDAQ
|
|
BAER
|
Julius Baer Gruppe AG
|
0.53%
|
CH
|
SW
|
|
WTW
|
Willis Towers Watson Public Limited Company
|
0.53%
|
US
|
NASDAQ
|
|
UHS
|
Universal Health Services, Inc.
|
0.53%
|
US
|
NYSE
|
|
HCA
|
HCA Holdings, Inc.
|
0.53%
|
US
|
NYSE
|
|
AFL
|
AFLAC Incorporated
|
0.53%
|
US
|
NYSE
|
|
GL
|
Globe Life Inc.
|
0.53%
|
US
|
NYSE
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
HALO
|
Halozyme Therapeutics, Inc.
|
0.52%
|
US
|
NASDAQ
|
|
AJG
|
Arthur J. Gallagher & Co.
|
0.52%
|
US
|
NYSE
|
|
GMED
|
Globus Medical, Inc.
|
0.51%
|
US
|
NYSE
|